See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.
See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.
See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.

Join Living Room Conversations, our civil dialogue partner, and America Indivisible for a nationwide conversation on April 13, Thomas Jefferson’s 276th birthday. "Reckoning with Jefferson: A Nationwide Conversation on Race, Religion, and the America We Want to Be" will be held via in-person and online video discussions. Sign up today!

Join Living Room Conversations, our civil dialogue partner, and America Indivisible for a nationwide conversation on April 13, Thomas Jefferson’s 276th birthday. "Reckoning with Jefferson: A Nationwide Conversation on Race, Religion, and the America We Want to Be" will be held via in-person and online video discussions. Sign up today!

Join Living Room Conversations, our civil dialogue partner, and America Indivisible for a nationwide conversation on April 13, Thomas Jefferson’s 276th birthday. "Reckoning with Jefferson: A Nationwide Conversation on Race, Religion, and the America We Want to Be" will be held via in-person and online video discussions. Sign up today!
Practical, engaging webinars designed to transform how you approach current events and facilitate productive classroom discussions.
The Art of Discussion - Civic Learning Week
Wednesday March 12, 2025 | 6:00 PM Eastern Time
Learn how to facilitate respectful dialogue across political and social divides using Mismatch, our platform for connecting students with diverse viewpoints.
Practical, engaging webinars designed to transform how you approach current events and facilitate productive classroom discussions.
The Art of Discussion - Civic Learning Week
Wednesday March 12, 2025 | 6:00 PM Eastern Time
Learn how to facilitate respectful dialogue across political and social divides using Mismatch, our platform for connecting students with diverse viewpoints.
Practical, engaging webinars designed to transform how you approach current events and facilitate productive classroom discussions.
The Art of Discussion - Civic Learning Week
Wednesday March 12, 2025 | 6:00 PM Eastern Time
Learn how to facilitate respectful dialogue across political and social divides using Mismatch, our platform for connecting students with diverse viewpoints.
See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.
See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.
See How AllSides Rates Other Media Outlets
We have rated the bias of nearly 600 outlets and writers!
See some of the most popular below:
Want to see more?
Check out the AllSides Media Bias Chart, or go to our Media Bias Ratings page to see everything.
Support AllSides
Please consider becoming a sustaining member or making a one-time donation to help keep AllSides online.
Support AllSides
Please consider becoming a sustaining member or making a one-time donation to help keep AllSides online.
Support AllSides
Please consider becoming a sustaining member or making a one-time donation to help keep AllSides online.
Hydroxychloroquine, the anti-malarial drug once touted by President Donald Trump as a potential COVID-19 coronavirus cure, remains a point of contention more than four months into the pandemic. This week, Trump and White House trade adviser Peter Navarro each defended their support for the drug to reporters. Some officials are pushing for more investment and research into hydroxychloroquine; others worry that focusing on the drug could crowd out investment into other potential COVID-19 treatments.
The hydroxychloroquine controversy has been covered by news outlets on all sides. Some coverage from left-rated outlets framed Trump administration support for the drug as questionable. Coverage of the drug's effectiveness is more nuanced, as journalists attempt to explain complex medical studies. However, evidence supporting hydroxychloroquine tends to be found in right-rated outlets, while evidence against the drug tends to be found in left-rated outlets.